Managed Healthcare Executive October 17, 2023
Briana Contreras

Patient affordability and access to specialty drugs and cell and gene therapies are just a couple of priorities self-insured employers should keep in mind when managing specialty spend, according to Shawna Ricker, PharmD, clinical pharmacist consultant of Clinical Client Strategy at Highmark,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Insurance, Pharma, Pharma / Biotech, Self-insured, Trends
Accolade Gets a Do-Over With Transcarent’s $621M Acquisition
Transcarent to buy Accolade for $621M
Transcarent to acquire fellow health benefits navigator Accolade for $621M
Transcarent To Acquire Accolade
Transcarent to acquire Accolade for $621 million

Share This Article